40 related articles for article (PubMed ID: 10412801)
1. Dementia of frontal type and dementias with subcortical gliosis.
Mann DM
Brain Pathol; 1998 Apr; 8(2):325-38. PubMed ID: 9546290
[TBL] [Abstract][Full Text] [Related]
2. Neuronal Injury and Glial Changes Are Hallmarks of Open Field Blast Exposure in Swine Frontal Lobe.
Kallakuri S; Desai A; Feng K; Tummala S; Saif T; Chen C; Zhang L; Cavanaugh JM; King AI
PLoS One; 2017; 12(1):e0169239. PubMed ID: 28107370
[TBL] [Abstract][Full Text] [Related]
3. Colocalization of BRCA1 with Tau Aggregates in Human Tauopathies.
Kurihara M; Mano T; Saito Y; Murayama S; Toda T; Iwata A
Brain Sci; 2019 Dec; 10(1):. PubMed ID: 31861888
[TBL] [Abstract][Full Text] [Related]
4. The fourth element targeting hypothesis of Alzheimer's disease pathogenesis and pathophysiology.
Kuljiš RO
Front Neurol; 2010; 1():144. PubMed ID: 21188267
[TBL] [Abstract][Full Text] [Related]
5. Oxidative damage to the promoter region of SQSTM1/p62 is common to neurodegenerative disease.
Du Y; Wooten MC; Wooten MW
Neurobiol Dis; 2009 Aug; 35(2):302-10. PubMed ID: 19481605
[TBL] [Abstract][Full Text] [Related]
6. Evidence of DNA damage in Alzheimer disease: phosphorylation of histone H2AX in astrocytes.
Myung NH; Zhu X; Kruman II; Castellani RJ; Petersen RB; Siedlak SL; Perry G; Smith MA; Lee HG
Age (Dordr); 2008 Dec; 30(4):209-15. PubMed ID: 19424844
[TBL] [Abstract][Full Text] [Related]
7. Tau aggregation and progressive neuronal degeneration in the absence of changes in spine density and morphology after targeted expression of Alzheimer's disease-relevant tau constructs in organotypic hippocampal slices.
Shahani N; Subramaniam S; Wolf T; Tackenberg C; Brandt R
J Neurosci; 2006 May; 26(22):6103-14. PubMed ID: 16738255
[TBL] [Abstract][Full Text] [Related]
8. Cell death mechanisms in neurodegeneration.
Jellinger KA
J Cell Mol Med; 2001; 5(1):1-17. PubMed ID: 12067447
[TBL] [Abstract][Full Text] [Related]
9. Tau-positive glial inclusions in progressive supranuclear palsy, corticobasal degeneration and Pick's disease.
Komori T
Brain Pathol; 1999 Oct; 9(4):663-79. PubMed ID: 10517506
[TBL] [Abstract][Full Text] [Related]
10. KP1 expression of ghost Pick bodies, amyloid P-positive astrocytes and selective nigral degeneration in early onset Picks disease.
Kobayashi K; Hayashi M; Fukutani Y; Miyazu K; Shiozawa M; Muramori F; Aoki T; Koshino Y
Clin Neuropathol; 1999; 18(5):240-9. PubMed ID: 10505433
[TBL] [Abstract][Full Text] [Related]
11. Pick's disease: a modern approach.
Dickson DW
Brain Pathol; 1998 Apr; 8(2):339-54. PubMed ID: 9546291
[TBL] [Abstract][Full Text] [Related]
12. Neuronal and glial DNA fragmentation in Pick's disease.
Gleckman AM; Jiang Z; Liu Y; Smith TW
Acta Neuropathol; 1999 Jul; 98(1):55-61. PubMed ID: 10412801
[TBL] [Abstract][Full Text] [Related]
13. Lobar atrophy without Pick bodies.
Hulette CM; Crain BJ
Clin Neuropathol; 1992; 11(3):151-6. PubMed ID: 1611728
[TBL] [Abstract][Full Text] [Related]
14. Neuronal and glial tau pathology in early frontotemporal lobar degeneration-tau, Pick's disease subtype.
Mimuro M; Yoshida M; Miyao S; Harada T; Ishiguro K; Hashizume Y
J Neurol Sci; 2010 Mar; 290(1-2):177-82. PubMed ID: 20022024
[TBL] [Abstract][Full Text] [Related]
15. Severity of gliosis in Pick's disease and frontotemporal lobar degeneration: tau-positive glia differentiate these disorders.
Schofield E; Kersaitis C; Shepherd CE; Kril JJ; Halliday GM
Brain; 2003 Apr; 126(Pt 4):827-40. PubMed ID: 12615642
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
